VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding VivoSim Labs, INC. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 34 | 1 | 31 | −2 |
| Shares | 2.33M | 142.2K | 2.44M | +255.1K (+11.7%) |
| Value | $1.77M | $108.4K | $1.24M | −$422.9K (−25.4%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held VivoSim Labs, INC. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 142,208 | $72.4K | 0.00% |
| XTX Topco Ltd | 17,503 | $8.91K | 0.00% |
| Allworth Financial LP | 2,500 | $1.27K | 0.00% |
| Federation des caisses Desjardins du Quebec | 3 | $2 | 0.00% |
Sold out (6)
Institutions that held VivoSim Labs, INC. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| FMR LLC | 455 | $347 |
| Kelly Financial Services LLC | 168 | $128 |
| Toronto Dominion Bank | 76 | $58 |
| Redwood Wealth Management Group, LLC | 25 | $19 |
| TD Waterhouse Canada Inc. | 10 | $8 |
| Simplex Trading, LLC | 134 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held VivoSim Labs, INC. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 142,208 | $108.4K |